MYOS RENS is evaluating the genotypic characteristics and molecular pathways that contribute to the changes seen in muscle and inflammatory disease states associated with sarcopenia and related disorders.
MYOS RENS takes its responsibility to the environment and the community very seriously. MYOS RENS is committed to being a good corporate citizen and welcomes suggestions on enhancing our contributions in this regard.
Award Winning Trainer Scott Keppel to Administer Challenge on the Vimify Mobile App
Initiative to Promote Qurr® as a Vital Component of a Regular Workout Regimen Geared to Quickly Put People Back on Track for Their Long-Term Fitness Goals
CEDAR KNOLLS, N.J., Jan. 16, 2018 /PRNewswire/ -- MYOS RENS Technology Inc. ("MYOS" or "the [...]
CEDAR KNOLLS, N.J., Jan. 11, 2018 /PRNewswire/ -- Today, the CEO of MYOS RENS Technology Inc. ("MYOS" or "the Company") (Nasdaq: MYOS), Joseph Mannello, issued the following letter to shareholders:
Dear Fellow Shareholders,
I would like to take this opportunity to wish you all a very happy, healthy and prosperous [...]